Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1641 1677 1678
This examiner grants 55% of resolved cases
Nam P Nguyen works in Art Unit 1641 of Tech Center 1600. The examiner has 336 resolved cases with an allowance rate of 54.2%. This rate indicates the proportion of applications that are granted. The 336 cases provide the foundation for this statistical analysis.
The median days to allowance is 1336. This figure represents the time required for applications to reach a grant. Practitioners can use the 1336-day median to forecast the length of the prosecution process. This duration is a consistent metric across the 336 resolved cases.
The interview lift for this examiner is 47.8%. This lift shows the change in the probability of allowance when an interview is conducted relative to the 54.2% baseline. An interview may be a strategic choice to navigate the 1336-day timeline. These figures together define the prosecution profile in Art Unit 1641.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18341906 | METHOD | Non-Final OA | Oxford Nanopore Technologies PLC |
| 18669218 | SYNTHETIC CONTROLS FOR IMMUNOHISTOCHEMISTRY | Non-Final OA | Genentech, Inc. |
| 17250536 | COMPLEX STABILIZING COMPONENTS AND DETECTION METHODS THEREOF | Non-Final OA | Siemens Healthcare Diagnostics Inc. |
| 17259601 | INTRAMOLECULAR KINETIC PROBES | Final Rejection | The Regents of the University of Michigan |
| 18480489 | TEMPORAL TRAUMATIC BRAIN INJURY BIOMARKERS AND METHODS OF USE THEREOF | Final Rejection | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY |
| 18637055 | CONCENTRATION-DEPENDENT SELF-INTERACTION ASSAY | Non-Final OA | Regeneron Pharmaceuticals, Inc. |
| 17838568 | PARTICLE-BASED IMMUNOASSAY USING A PEGYLATED ANALYTE-SPECIFIC BINDING AGENT | Final Rejection | Roche Diagnostics Operations, Inc. |
| 15892829 | ALKALINE PRETREATMENT OF PARVOVIRUSES FOR IMMUNOASSAYS | Non-Final OA | Roche Diagnostics Operations, Inc. |
| 18299833 | POLYPEPTIDE, MULTIMER, SOLID PHASE, MEASUREMENT METHOD FOR TEST SUBSTANCE, AND REAGENT KIT | Final Rejection | SYSMEX CORPORATION |
| 18127568 | Tandem Dyes Having Internally Positioned Sensors, and Methods for Making and Using the Same | Non-Final OA | Becton, Dickinson and Company |
| 18349867 | PEGBOARD PROTEIN PURIFICATION PLATE FOR HIGH THROUGHPUT PROTEIN CHARACTERIZATION | Non-Final OA | Alliance for Energy Innovation, LLC |
| 18266665 | METHOD FOR MEASURING RELATIVE fu RATIO BY DYNAMIC ANALYSIS | Final Rejection | Chugai Seiyaku Kabushiki Kaisha |
| 17265756 | COMPOSITIONS AND METHODS FOR DETECTION AND IMAGING OF AMYLOID FIBRILS, AMYLOID PLAQUES, RNA, AND NUCLEOLI | Final Rejection | The University of Hong Kong |
| 17284875 | Fc Variants with Altered Binding to Neonatal Fc Receptor (FCRN) for Veterinary Use | Final Rejection | Elanco US Inc. |
| 18260018 | CIRCULATING TRANSCRIPTION FACTOR ANALYSIS | Non-Final OA | Belgian Volition SRL (BE/BE) |
| 18132746 | COMPOSITIONS AND METHODS FOR THE DETECTION AND MOLECULAR PROFILING OF MEMBRANE BOUND VESICLES WITH NANOPARTICLES | Final Rejection | The University of Memphis Research Foundation |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy